Showing 5,845 results

Filters Content type: News, Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Injectable & long-acting HIV treatment

Emerging options: Doctors and advocates discuss treatment and prevention breakthroughs on the horizon

Editor's pick
Positively Aware
30 January 2019
Ageing & HIV

Is ageing in people living with HIV accelerated or accentuated?

News
30 January 2019
Child developmental issues

South Africa urgently needs an antiretroviral pregnancy registry

Editor's pick
Spotlight
29 January 2019
Testing & health monitoring

For Our Stable HIV Patients, Why Are We Still Sending All These Lab Tests So Often?

Editor's pick
NEJM Journal Watch
29 January 2019
HIV treatment

Six advantages of dolutegravir

Editor's pick
Spotlight SA
28 January 2019
Bad science & bogus treatments

Quest to Solve Assassination Mystery Revives an AIDS Conspiracy Theory

Editor's pick
New York Times
28 January 2019
HIV treatment

Dolutegravir- why new does not automatically mean better

Editor's pick
Spotlight
25 January 2019
Behaviour change interventions

Uganda: Financial incentives do not boost HIV viral suppression rate

Editor's pick
Healio
25 January 2019
Treatment guidelines

HIV care is threatened by proposed changes to Medicare Part D

Editor's pick
STAT
25 January 2019
Access to healthcare

Indonesia turns to Global Fund to ensure ARV stock

Editor's pick
The Jakarta Post
23 January 2019
Changing treatment

FDA To Consider Pifeltro, Delstrigo as HIV Switch-On Therapies

Editor's pick
MD Magazine
23 January 2019
Retention & linkage to care

What stops people with HIV adhering to long term antiretroviral therapy?

Editor's pick
BMC Blogs Network
22 January 2019
Bad science & bogus treatments

China confirms birth of gene-edited babies, blames scientist He Jiankui for breaking rules

Editor's pick
South China Morning Post
21 January 2019
Treatment outcomes & life expectancy

Atripla or efavirenz plus Truvada failed one in 16 people in first year

News
21 January 2019
New & experimental HIV treatments

South Africa: New safety concerns emerge on latest HIV wonder drug

Editor's pick
Business Day
18 January 2019
Child developmental issues

Efavirenz in pregnancy is at least as safe as other antiretrovirals

News
17 January 2019
Opportunistic infections

Back to the future with CD4 testing: Improving HIV care in low- and middle-income countries

Editor's pick
Science Daily
16 January 2019
New & experimental HIV treatments

Dolutegravir monotherapy 'not a valid option' for patients with HIV

Editor's pick
Healio
15 January 2019
Sleep

Sleep Abnormalities Do Not Reverse After Discontinuing Efavirenz

Editor's pick
Infectious Disease Advisor
14 January 2019
Side effects

Do integrase inhibitors raise the risk of obesity?

News
10 January 2019
Treatment simplification strategies

Dolutegravir Monotherapy for HIV No Longer Recommended

Editor's pick
Contagion Live
9 January 2019
Drug interactions & pharmacokinetics

Potential drug interactions among people with HIV taking statins

News
9 January 2019
Low CD4 count

‘Left behind’: Drug companies and researchers have overlooked patients who don’t respond to HIV meds

Editor's pick
STAT
8 January 2019
Starting treatment

‘RAPID’ HIV treatment initiation a success in San Francisco

Editor's pick
AVERT
8 January 2019